Pampanga gets third batch of AstraZeneca, Sinovac vaccines | Inquirer News

Pampanga gets third batch of AstraZeneca, Sinovac vaccines

/ 04:49 PM March 21, 2021

Cameroon suspends use of AstraZeneca vaccine

FILE PHOTO: A medical worker prepares a dose of Oxford/AstraZeneca’s COVID-19 vaccine at a vaccination center in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman

CITY OF SAN FERNANDO— Pampanga on Sunday (March 21) received 5,020 doses of COVID-19 vaccines produced by British-Swede drugmaker AstraZeneca and 432 vaccine doses from Chinese pharmaceutical firm Sinovac Biotech Ltd, which are the third set of vaccines to be allocated to the province.

The latest shipment from the Department of Health are for medical frontliners who have not received their first injections during the first wave of inoculations this month, according to Dr. Ming Ignacio, provincial health officer.

ADVERTISEMENT

The initial sets consisting of 846 doses of the Sinovac vaccine and 5,130 doses of the AstraZeneca vaccine arrived on March 8 and 12, respectively.

The 600,000 doses of the AstraZeneca vaccine, which was purchased by the provincial government, are due to arrive in June or July, according to Pampanga Gov. Dennis Pineda.  INQ

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: AstraZeneca, COVID-19, Pampanga, Sinovac, Vaccines

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.